全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

基于CiteSpace的中医药治疗慢性糜烂性胃炎的可视化分析
Visual Analysis of Traditional Chinese Medicine for the Treatment of Chronic Erosive Gastritis Based on CiteSpace

DOI: 10.12677/md.2024.143048, PP. 332-343

Keywords: CiteSpace,可视化分析,中医药,慢性糜烂性胃炎
CiteSpace
, Visual Analysis, Traditional Chinese Medicine, Chronic Erosive Gastritis

Full-Text   Cite this paper   Add to My Lib

Abstract:

目的:利用CiteSpace软件探究中医药治疗慢性糜烂性胃炎的研究热点、前沿及趋势,为后续科研提供参考。方法:在中国知网(CNKI)、维普(VIP)、万方(WangFang)数据库中检索发表时间为2004年1月1日至2024年3月31日的有关中医药治疗慢性糜烂性胃炎的有关文献。利用CiteSpace6.3.1对纳入文献的发文量、作者、时间及关键词进行可视化分析并绘制相关图谱。结果:最终纳入576篇文献。发文量先呈直线上升后再保持稳定状态;发文量较高的作者团队是以王彦刚为核心的团队;发文量最多的机构为南京中医药大学;目前的研究热点为中医药疗法、中西医结合疗法、康复新液;未来研究前沿可能为不良反应、临床效果、隆起糜烂性胃炎。结论:该领域未来仍有良好的发展前景。未来研究者应加强团队与团队之间以及多机构共同合作,促进中医药在此领域的发展。
Objective: To explore the research hotspots, frontiers and trends of traditional Chinese medicine (TCM) in the treatment of chronic erosive gastritis by utilizing CiteSpace software, and to provide references for subsequent scientific research. Methods: The relevant literature on the treatment of chronic erosive gastritis with traditional Chinese medicine published between January 1, 2004 and March 31, 2024 was searched in CNKI, VIP and WangFang databases. CiteSpace6.3.1 was used to visually analyze the number of publications, authors, time and keywords of the included literatures and draw the relevant maps. Results: 576 literatures were finally included. The number of publications first increased linearly and then remained stable; the author team with the highest number of publications was Wang Yangang; the institution with the highest number of publications was Nanjing University of Traditional Chinese Medicine; the current hotspots of research are traditional Chinese medicine therapy, combined therapies of traditional Chinese medicine and western medicine, and Kangfuxin solution; and the future frontiers of research may be adverse reactions, clinical effects, raised erosive gastritis. Conclusion: This field still has good prospects for future development. Future researchers should strengthen team-to-team and multi-institutional joint cooperation to promote the development of TCM in this field.

References

[1]  Chinese Society of Gastroenterology, Cancer Collaboration Group of Chinese Society of Gastroenterology and Chinese Medical Association (2023) Guidelines for Diagnosis and Treatment of Chronic Gastritis in China(2022, Shanghai). Journal of Digestive Diseases, 24, 150-180.
https://doi.org/10.1111/1751-2980.13193
[2]  Yang, Y., Li, K., Xu, G., Wang, C., Xiong, H., Wang, X., et al. (2024) Clinical Manifestation, Lifestyle, and Treatment Patterns of Chronic Erosive Gastritis: A Multicenter Real-World Study in China. World Journal of Gastroenterology, 30, 1108-1120.
https://doi.org/10.3748/wjg.v30.i9.1108
[3]  南青山, 舒劲, 于建荣. 中医治疗慢性糜烂性胃炎研究进展[J]. 实用中医药杂志, 2023, 39(4): 823-826.
[4]  郭蕾, 李志钢, 穆凯代斯·阿布都热合曼. 慢性糜烂性胃炎的中医治法概述[J]. 新疆中医药, 2022, 40(6): 131-134.
[5]  Jia, W., Peng, J. and Cai, N. (2020) An Approach to Improving the Analysis of Literature Data in Chinese through an Improved Use of Citespace. Knowledge Management & E-Learning, 12, 256-267.
[6]  张琪, 盛武. 基于CiteSpace对国内智能矿山领域数字孪生的可视化分析[J]. 兰州工业学院学报, 2024, 31(2): 85-90.
[7]  Jiang, J., Xu, S., Ma, H., Li, C. and Huang, Z. (2023) Photoresponsive Hydrogel-Based Soft Robot: A Review. Materials Today Bio, 20, Article 100657.
https://doi.org/10.1016/j.mtbio.2023.100657
[8]  Ye, Z., Mai, T., Cheng, Y., Zhang, X., Liu, Z., Zhang, Z., et al. (2023) Neurotoxicity of Microplastics: A Citespace-Based Review and Emerging Trends Study. Environmental Monitoring and Assessment, 195, Article No. 960.
https://doi.org/10.1007/s10661-023-11559-1
[9]  Zheng, D., Wu, Z., Li, L., Chen, S. and Chang, J. (2023) Research Advances and Trends in the Surgical Treatment of Carpal Tunnel Syndrome from 2003 to 2022: A Citespace-Based Bibliometric Analysis. Frontiers in Neurology, 14, Article 1124407.
https://doi.org/10.3389/fneur.2023.1124407
[10]  周平平, 王彦刚, 集川原, 等. 国医大师李佃贵以化浊解毒方治疗慢性糜烂性胃炎经验[J]. 中国中医药信息杂志, 2020, 27(1): 103-105.
[11]  王彦刚, 吕静静, 周盼盼. 化浊解毒方对慢性糜烂性胃炎浊毒内蕴证患者HGF/c-Met信号通路影响的研究[J]. 中药药理与临床, 2017, 33(2): 186-189.
[12]  毛欣欣, 欧阳洁, 柯晓, 等. 健脾清化散瘀饮对脾虚湿热血瘀型RGE患者IL-8、TNF-α、IL-10及EGF、b FGF表达的影响[J]. 光明中医, 2019, 34(14): 2147-2149.
[13]  徐兆山, 王霞, 田敏, 等. 益气和胃清热祛瘀法治疗疣状胃炎的临床研究[J]. 中医药导报, 2016, 22(23): 91-93.
[14]  安晓霞, 王振刚, 卢杰夫, 等. 慢性糜烂性胃炎中医体质特点及其与胃黏膜微形态的相关性[J]. 广西中医药, 2019, 42(4): 1-4.
[15]  贝鸽, 徐陆周. 徐陆周运用加味芩蒲饮治疗慢性糜烂性胃炎[J]. 河南中医, 2019, 39(10): 1507-1510.
[16]  鲁颖珂, 田耀洲. 田耀洲教授从肝论治慢性糜烂性胃炎的经验[J]. 中国当代医药, 2023, 30(19): 86-90.
[17]  张秋霞, 张影, 张雅文, 等. 基于古今医案云平台系统探析慢性糜烂性胃炎临床症状-证候-用药规律[J]. 首都医科大学学报, 2023, 44(3): 463-469.
[18]  周文功, 刘燕平. 慢性糜烂性胃炎中医证型和证素研究综述[J]. 江西中医药大学学报, 2017, 29(5): 109-111.
[19]  陈艳, 王文荣, 唐朝宏, 等. 清化散瘀饮治疗脾胃湿热型隆起糜烂性胃炎30例[J]. 福建中医药, 2022, 53(6): 9-11.
[20]  胡毅, 何晓娟. 清胃祛湿汤联合奥美拉唑肠溶片治疗糜烂性胃炎脾胃湿热型效果观察[J]. 实用中医药杂志, 2019, 35(12): 1487-1488.
[21]  黄雅辉. 三参胃炎汤治疗慢性糜烂性胃炎的临床疗效[J]. 中国医药指南, 2024, 22(5): 111-114.
[22]  范方方, 阿英. 柴胡疏肝散合左金丸结合西药治疗慢性糜烂性胃炎临床研究[J]. 光明中医, 2024, 39(1): 104-106.
[23]  陈慧, 李春平, 胡光宏, 等. 八段锦联合健脾清化散瘀饮治疗脾虚湿热血瘀型隆起糜烂性胃炎36例[J]. 福建中医药, 2022, 53(4): 58-60.
[24]  陈才凤. 兰索拉唑与中药联合治疗脾胃湿热型慢性糜烂性胃炎的效果分析[J]. 中外医疗, 2022, 41(10): 9-12+31.
[25]  万昌俭. 中西医结合治疗糜烂性胃炎疗效观察[J]. 山西中医, 2022, 38(7): 39-40.
[26]  杨保勤. 疣状胃炎应用内镜介入联合中药治疗的效果观察[J]. 首都食品与医药, 2019, 26(23): 36-37.
[27]  王鹏伟, 杨菲, 曹文秋. 美洲大蠊提取物康复新液在国内外临床应用的研究进展[J]. 今日药学, 2023, 33(10): 784-788.
[28]  杨梦, 王婧. 康复新液治疗慢性糜烂性胃炎的疗效[J]. 深圳中西医结合杂志, 2020, 30(19): 88-89.
[29]  卢华节. 柴胡疏肝散合左金丸加减治疗慢性糜烂性胃炎的疗效及不良反应发生率评价[J]. 现代诊断与治疗, 2021, 32(15): 2374-2375.
[30]  余修斌. 三参胃炎汤治疗慢性糜烂性胃炎的临床疗效观察及效果评价[J]. 实用中医内科杂志, 2019, 33(10): 63-65.
[31]  毛志刚. 中药汤剂联合抗Hp四联疗法治疗隆起糜烂性胃炎临床研究[J]. 光明中医, 2023, 38(9): 1746-1749.
[32]  王云利. 中药汤剂联合抗Hp四联疗法治疗隆起糜烂性胃炎临床分析[J]. 中文科技期刊数据库(引文版)医药卫生, 2024(1): 115-118.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133